Stock 002022 SHANGHAI KEHUA BIO-ENGINEERING CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Shanghai Kehua Bio-Engineering Co.,Ltd

Equities

002022

CNE000001KC9

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-06-30 EDT 		5-day change 1st Jan Change
5.69 CNY +0.71% Intraday chart for Shanghai Kehua Bio-Engineering Co.,Ltd +1.07% -50.00%
06-13 Kehua Bio-Engineering's Growth Factor Kit Gets Registration Certificate MT
04-28 Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Kehua Bio-Engineering's Growth Factor Kit Gets Registration Certificate
MT
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Kehua Bio-Engineering Gets Registration Certificates for Two Devices
MT
Tranche Update on Shanghai Kehua Bio-Engineering Co.,Ltd's Equity Buyback Plan announced on October 29, 2023.
CI
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Kehua Bio-Engineering Gets Nod to Register Protein Detection Kit
MT
Xi'an Zhitong Benyi Enterprise Management Partnership Enterprise (Limited Partnership) completed the acquisition of 5% stake in Shanghai Kehua Bio-Engineering Co.,Ltd from Zhuhai Baolian Asset Management Co., Ltd.
CI
Shanghai Kehua Bio-Engineering Gets Approval for Leucine Aminopeptidase Kit
MT
Xi'an Zhitong Benyi Enterprise Management Partnership Enterprise (Limited Partnership) agreed to acquire 5% stake in Shanghai Kehua Bio-Engineering Co.,Ltd from Zhuhai Baolian Asset Management Co., Ltd. for CNY 514.3 million.
CI
Tranche Update on Shanghai Kehua Bio-Engineering Co.,Ltd's Equity Buyback Plan announced on October 29, 2023.
CI
Shanghai Kehua Bio-Engineering Co.,Ltd announces an Equity Buyback for CNY 200 million worth of its shares.
CI
Shanghai Kehua Bio-Engineering Co.,Ltd authorizes a Buyback Plan.
CI
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Shanghai Kehua Bio-Engineering Co.,Ltd Approves Cash Dividend for the Year 2022, Payable on 10 May 2023
CI
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Shanghai Kehua Bio-Engineering Co.,Ltd Approves Cash Dividend for 2022
CI
Shanghai Kehua Bio-Engineering Co.,Ltd Proposes Final Cash Dividend for the Year 2022
CI
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 002022 Stock
  4. News Shanghai Kehua Bio-Engineering Co.,Ltd
  5. Highlights